Beta-2-Glucoprotein 1 - 1.0mg

Beta-2-Glucoprotein 1 - 1.0mg

Regular price
$738.50
Regular price
Sale price
$738.50
Unit price
per 
Availability
Sold out

Beta-2-Glucoprotein 1
Apolipoprotein H
APOH
Activated protein C-binding protein
APC inhibitor
Uniprot ID:  P02749
mRNA RefSeq:  NM_000042
Protein RefSeq:  NP_000033

Size: 1.0mg
Source: Human Plasma

Product Information:

Autoantibodies directed to negatively charged phospholipids, in particular cardiolipin, have been detected in the serum of patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). APS is characterised by venous and arterial thrombosis, recurrent spontaneous abortions and thrombocytopenia. It is now known that a serum cofactor, β2-glycoprotein 1, is required for the binding of cardiolipin by autoantibodies in the sera of patients with APS. By contrast, anticardiolipin antibodies from patients with infectious diseases (in particular, syphilis) do not require this cofactor.

β2-Glycoprotein 1, also known as apolipoprotein H, is a relatively abundant serum protein (present at a concentration of about 0.2 mg/ml) that may play a role in coagulation. It has been shown to bind to platelets, mitochondria and negatively charged substances such as heparin, DNA, dextran sulphate and negatively charged phospholipids.

β2-Glycoprotein 1 is known to be very heat stable. On SDS-electrophoresis the protein displays an apparent molecular weight of ~55 kDa reduced and ~45kDa in non-reduced conditions. Isoelectric focussing has been reported to reveal genetic polymorphisms of β2-glycoprotein 1, the multiple bands seen by this method may be due to different amounts of sialic acid. The amino acid sequence of β2-glycoprotein 1 reveals a 326 amino acid protein of about 36 kDa. This sequence has been confirmed by sequencing the protein’s cDNA. The fact that the protein migrates on SDS-electrophoresis with a much larger apparent m.wt., suggests that it is extensively glycosylated. β2-Glycoprotein 1 has five consensus repeats, referred to as "Sushi domains", characteristic of the complement control protein family.


PDF-logo-dl Beta-2-Glycoprotein 1 datasheet

Clinical Indications:

Antiphospholipid Syndrome
Systemic Lupus Erythematosus

MSDS:

References:

Hughes, G.R.V. (1994) Lancet 342, 341

Galli, M. et al. (1990) Lancet 335, 1544

Matsuura, E. et al. (1990) Lancet 336, 177

McNeil, H.P. et al. (1991) Proc. Natl. Acad. Sci. USA 87, 4120

Matsuura, E. et al. (1992) J. Immunol. 148, 3885

Schousboe, I. (1985) Blood 66, 1086

Schousboe, I. (1980) Thromb. Res. 19, 225

Schousboe, I. (1979) Biochim. Biophys. Acta 579, 396

Polz et al. (1980) Int. J. Biochem. 11, 265

Kroll, J. et al. (1976) Biochim. Biophys. Acta 434, 490

Schousboe, I. & Rasmussen, M.S. (1988) Int. J. Biochem. 20, 787

Wurm, H. (1984) Int. J. Biochem. 16, 511

Richter, A. & Cleve, H. (1988) Electrophoresis 9, 317

Gries, A. et al. (1989) Biochem. J. 260, 531

Lozier, J. et al. (1984) Proc. Natl. Acad. Sci. USA 81, 3640

Steinkasserer, A. et al. (1991) Biochem. J. 277, 387

Kato, H. & Enjyoji, K. (1991) Biochem. USA 30, 11687

Ichinose, A. et al. (1990) J. Biol. Chem. 265, 13411

Amiral, J. et al. (1994) Haemostasis 24, 191

Arvieux, J. et al. (1991) J. Immunol. Methods 143, 223

Cabral, A.R. et al. (1992) J. Autoimmunity 5, 787

El-Kadi, H.S. et al. (1995) J. Rheumatol. 22, 2233

Erickson, E.N. et al. (1996) Clin. Chem. 42, 1116

Gharavi, A.E. et al. (1993) J. Lab. Clin. Med. 122, 426

Hanly, J.G. et al. (1995) J. Rheumatol. 22, 1091

Hunt, J. & Krilis, S. (1994) J. Immunol. 152, 653

Katano, K. et al. (1996) Human Reprod. 11, 509

Keil, L.B. et al. (1995) Biotechnol. Appl. Biochem. 22, 305

Martinuzzo, M.E. et al. (1995) Brit. J. Haemotol. 89, 397

Matsuura, E. et al. (1992) J. Immunol. 148, 3885

McNally, T. et al. (1995) Brit. J. Haematol. 91, 471

Nomura, M. et al. (1995) Rheumatol. Int. 15, 1

Pengo, V. et al. (1995) Thrombosis & Haemostasis 73, 29

Roubey, R.A.S. et al. (1995) J. Immunol. 154, 954

Matsuura, E. et al. (1994) J. Exp. Med. 179, 457

Arvieux, J. & Roussel, B. (1994) Brit. J. Haemotol. 88, 443

Matsuda, J. et al. (1993) Brit. J. Haemotol. 85, 799

Cheng, H.W. (1996) J. Immunol. Methods 191, 87